Most Recent
Trader Daniel Schlaepfer and his firm Select Vantage are seeking over $10 million in damages from the Australian Securities and Investments Commission in a defamation action against the corporate regulator, a court heard Thursday on the fourth day of trial in the case.
Australia's largest independent coal producer Whitehaven Coal Mining has been convicted and fined $38,500 after potentially harmful gas drifted from one of its mines across neighbouring farmland.
A judge has rejected a motion by the NSW government and 15 local health districts to shut down a class action by the relatives of overseas patients who were forced to serve as guarantors and hit with hospital bills worth tens of thousands of dollars.
The Australian Securities and Investments Commission made global trading firm Select Vantage "vanish overnight" from the Australian market using slanderous statements based on a lack of evidence, the NSW Supreme Court has heard.
The Construction, Forestry, Maritime, Mining and Energy Union has appealed a ruling granting $1 million to the liquidators of failure labour hire company One Key Workforce that the union claimed was owed to its members.
The High Court has upheld a $1.3 million damages award to native title holders in the Northern Territory town of Timber Creek for their loss of spiritual attachment to the land, in the first ever assessment by the court of native title compensation.
The Construction, Forestry, Maritime, Mining and Energy union is seeking court approval to intervene in a class action against labour hire company WorkPac on behalf of casual miners who claim they were denied annual leave and other entitlements.
A former Qantas flight attendant who was sacked after getting drunk on peach martinis at a bar while off duty in Manhattan has lost an appeal of a finding that the airline had valid reasons for dismissing him.
The ABC paid ousted managing managing director Michelle Guthrie $730,000 to settle a lawsuit alleging unfair dismissal.
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.